Home > Healthcare > Medical Devices > Therapeutic Devices > Smart Inhalers Market

Smart Inhalers Market Trends

Report ID: GMI3994
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Smart Inhalers Market Trends

Continuous technological advancements in smart inhalers are projected to accelerate the market growth. As smart inhaler is a part of the new-age digital technology, these devices are being optimized to enhance respiratory ailment management. Enhanced availability of advanced smart inhaler to treat respiratory diseases will fuel the market revenue size.

Advanced devices offer several benefits such as medication history tracker & monitoring, clinical data collection, enhanced accuracy, and ease of use compared to conventional inhalers thereby, accelerating the demand for therapeutic respiratory devices.
Furthermore, strong presence of key market players that are proactively involved in innovative product development and launches will fuel industry landscape.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global smart inhalers industry size was USD 1.5 billion in 2022 and is estimated to account for USD 3.3 billion by 2032.

COPD held over 57% industry share in 2022 and will augment the market demand by 2032 due to aging population base, rising disease prevalence caused by continued exposure to risk factors such as tobacco smoke and air pollution, coupled with improved disease diagnosis.

U.S. smart inhalers market accounted for USD 520 million in 2022 and is predicted to witness substantial growth through 2032 owing to technological advancements coupled with substantial healthcare expenditure.

Adherium, Propeller Health, Nemera, GlaxoSmithKline Plc., Novartis AG, Aptar Group Inc, AstraZeneca Plc, Findair Sp. Z.o.o., BioCorp, Zeolr Technologies Pvt Ltd., Vectura Group Plc., Teva Pharmaceutical Industries Ltd., and Boehringer Ingelheim International GmbH.